Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thromboembolism 5Venous Thrombosis 4Pulmonary Embolism 4Neoplasms 4Thrombosis 2Neoplasm Metastasis 2Intracranial Thrombosis 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Multiple Myeloma 1Mesenteric Ischemia 1Lymphoma 1Hematologic Neoplasms 1

Interventions

apixaban 2edoxaban 1X-Rays 1Warfarin 1Technetium Tc 99m Sulfur Colloid 1Rivaroxaban 1Photons 1Fondaparinux 1Enoxaparin 1Dalteparin 1Dabigatran 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Thrombosis × apixaban × Clear all
NCT02744092 2023-10-03

CANVAS

Alliance Foundation Trials, LLC.

Phase NA Completed
811 enrolled 19 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT00320255 2016-08-16

A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer

Bristol-Myers Squibb

Phase 2 Completed
130 enrolled 22 charts

Neoplasms, Pulmonary Embolism, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡